Position in AVXL
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$5,771
-$921 QoQ
Shares Held
1,880
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026IAG Wealth Partners, LLC holds $63,754 across 6 Biotechnology names. AVXL ranks #5 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
33 | $25,497 | |
| 2 | HELP |
Cybin Inc.
|
2,750 | $13,200 | |
| 3 | IOVA |
Iovance Biotherapeutics, Inc.
|
2,620 | $9,196 | |
| 4 | LEGN |
Legend Biotech Corp
|
500 | $9,045 | |
| 5 | AVXL |
Anavex Life Sciences Corp.
This page
|
1,880 | $5,771 | |
| 6 | TECH |
BIO-TECHNE Corp
|
20 | $1,045 |
All Filings in AVXL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,771 | 1,880 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $6,692 | 1,880 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $16,732 | 1,880 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $17,333 | 1,880 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $16,130 | 1,880 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $20,191 | 1,880 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $10,678 | 1,880 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $7,933 | 1,880 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $9,569 | 1,880 | Shares | Sole | 2024-04-24 | |
| No filing history on record for this holder in this stock. | ||||||